The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Human Interleukin-2 Market Research Report 2025
Synopsis
Recombinant Human Interleukin-2 (IL-2) is a therapeutic protein used in medicine, particularly in immunotherapy. Interleukin-2 is a naturally occurring cytokine produced by activated T cells, and it plays a crucial role in regulating the immune response. Recombinant IL-2 is produced through genetic engineering techniques, where the IL-2 gene is inserted into host cells (such as bacteria, yeast, or mammalian cells) to produce large quantities of the protein.
The global Recombinant Human Interleukin-2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Recombinant Human Interleukin-2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Interleukin-2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Interleukin-2 include Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, Miltenyi Biotec, Akron Biotech, Sino Biological, Creative Bioarray, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Interleukin-2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Interleukin-2.
The Recombinant Human Interleukin-2 market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Interleukin-2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Interleukin-2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cytiva
Bio-Techne
Lonza
Sartorius CellGenix
Thermo Fisher Scientific
Miltenyi Biotec
Akron Biotech
Sino Biological
Creative Bioarray
Segment by Type
Pharmaceutical Grade
Other
Segment by Application
Medical
Culture Medium Supplement
Scientific Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Interleukin-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Interleukin-2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Recombinant Human Interleukin-2 (IL-2) is a therapeutic protein used in medicine, particularly in immunotherapy. Interleukin-2 is a naturally occurring cytokine produced by activated T cells, and it plays a crucial role in regulating the immune response. Recombinant IL-2 is produced through genetic engineering techniques, where the IL-2 gene is inserted into host cells (such as bacteria, yeast, or mammalian cells) to produce large quantities of the protein.
The global Recombinant Human Interleukin-2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Recombinant Human Interleukin-2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Interleukin-2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Interleukin-2 include Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, Miltenyi Biotec, Akron Biotech, Sino Biological, Creative Bioarray, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Interleukin-2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Interleukin-2.
The Recombinant Human Interleukin-2 market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Interleukin-2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Interleukin-2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cytiva
Bio-Techne
Lonza
Sartorius CellGenix
Thermo Fisher Scientific
Miltenyi Biotec
Akron Biotech
Sino Biological
Creative Bioarray
Segment by Type
Pharmaceutical Grade
Other
Segment by Application
Medical
Culture Medium Supplement
Scientific Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Interleukin-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Interleukin-2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Human Interleukin-2 Market Overview
1.1 Product Definition
1.2 Recombinant Human Interleukin-2 by Type
1.2.1 Global Recombinant Human Interleukin-2 Market Value Comparison by Type (2024-2030)
1.2.2 Pharmaceutical Grade
1.2.3 Other
1.3 Recombinant Human Interleukin-2 by Application
1.3.1 Global Recombinant Human Interleukin-2 Market Value by Application (2024-2030)
1.3.2 Medical
1.3.3 Culture Medium Supplement
1.3.4 Scientific Research
1.4 Global Recombinant Human Interleukin-2 Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Interleukin-2 Revenue 2019-2030
1.4.2 Global Recombinant Human Interleukin-2 Sales 2019-2030
1.4.3 Global Recombinant Human Interleukin-2 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Interleukin-2 Market Competition by Manufacturers
2.1 Global Recombinant Human Interleukin-2 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Interleukin-2 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Interleukin-2 Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Recombinant Human Interleukin-2, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Interleukin-2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Interleukin-2, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Interleukin-2, Date of Enter into This Industry
2.8 Global Recombinant Human Interleukin-2 Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Interleukin-2 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Interleukin-2 Players Market Share by Revenue
2.8.3 Global Recombinant Human Interleukin-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Interleukin-2 Market Scenario by Region
3.1 Global Recombinant Human Interleukin-2 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Interleukin-2 Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Interleukin-2 Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Interleukin-2 Sales by Region: 2025-2030
3.3 Global Recombinant Human Interleukin-2 Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Interleukin-2 Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Interleukin-2 Revenue by Region: 2025-2030
3.4 North America Recombinant Human Interleukin-2 Market Facts & Figures by Country
3.4.1 North America Recombinant Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Interleukin-2 Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Interleukin-2 Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Interleukin-2 Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Interleukin-2 Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Interleukin-2 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Interleukin-2 Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Interleukin-2 Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Interleukin-2 Sales by Region (2019-2030)
3.6.3 Asia Pacific Recombinant Human Interleukin-2 Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Interleukin-2 Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Interleukin-2 Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Interleukin-2 Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Interleukin-2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Interleukin-2 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Interleukin-2 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Interleukin-2 Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Interleukin-2 Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Interleukin-2 Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Interleukin-2 Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Interleukin-2 Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Interleukin-2 Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Interleukin-2 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Interleukin-2 Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Interleukin-2 Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Interleukin-2 Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Interleukin-2 Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Interleukin-2 Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Interleukin-2 Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Interleukin-2 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cytiva
6.1.1 Cytiva Company Information
6.1.2 Cytiva Description and Business Overview
6.1.3 Cytiva Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cytiva Recombinant Human Interleukin-2 Product Portfolio
6.1.5 Cytiva Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bio-Techne Recombinant Human Interleukin-2 Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Lonza
6.3.1 Lonza Company Information
6.3.2 Lonza Description and Business Overview
6.3.3 Lonza Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lonza Recombinant Human Interleukin-2 Product Portfolio
6.3.5 Lonza Recent Developments/Updates
6.4 Sartorius CellGenix
6.4.1 Sartorius CellGenix Company Information
6.4.2 Sartorius CellGenix Description and Business Overview
6.4.3 Sartorius CellGenix Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sartorius CellGenix Recombinant Human Interleukin-2 Product Portfolio
6.4.5 Sartorius CellGenix Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Thermo Fisher Scientific Recombinant Human Interleukin-2 Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Miltenyi Biotec
6.6.1 Miltenyi Biotec Company Information
6.6.2 Miltenyi Biotec Description and Business Overview
6.6.3 Miltenyi Biotec Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Miltenyi Biotec Recombinant Human Interleukin-2 Product Portfolio
6.6.5 Miltenyi Biotec Recent Developments/Updates
6.7 Akron Biotech
6.7.1 Akron Biotech Company Information
6.7.2 Akron Biotech Description and Business Overview
6.7.3 Akron Biotech Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Akron Biotech Recombinant Human Interleukin-2 Product Portfolio
6.7.5 Akron Biotech Recent Developments/Updates
6.8 Sino Biological
6.8.1 Sino Biological Company Information
6.8.2 Sino Biological Description and Business Overview
6.8.3 Sino Biological Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sino Biological Recombinant Human Interleukin-2 Product Portfolio
6.8.5 Sino Biological Recent Developments/Updates
6.9 Creative Bioarray
6.9.1 Creative Bioarray Company Information
6.9.2 Creative Bioarray Description and Business Overview
6.9.3 Creative Bioarray Recombinant Human Interleukin-2 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Creative Bioarray Recombinant Human Interleukin-2 Product Portfolio
6.9.5 Creative Bioarray Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Interleukin-2 Industry Chain Analysis
7.2 Recombinant Human Interleukin-2 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Interleukin-2 Production Mode & Process
7.4 Recombinant Human Interleukin-2 Sales and Marketing
7.4.1 Recombinant Human Interleukin-2 Sales Channels
7.4.2 Recombinant Human Interleukin-2 Distributors
7.5 Recombinant Human Interleukin-2 Customers
8 Recombinant Human Interleukin-2 Market Dynamics
8.1 Recombinant Human Interleukin-2 Industry Trends
8.2 Recombinant Human Interleukin-2 Market Drivers
8.3 Recombinant Human Interleukin-2 Market Challenges
8.4 Recombinant Human Interleukin-2 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant Human Interleukin-2 Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Interleukin-2 Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Interleukin-2 Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Interleukin-2 Sales (kg) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Interleukin-2 Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Interleukin-2 Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Interleukin-2 Average Price (US$/g) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Interleukin-2, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Interleukin-2, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Interleukin-2, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Interleukin-2, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Interleukin-2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Interleukin-2 as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Interleukin-2 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Interleukin-2 Sales by Region (2019-2024) & (kg)
Table 18. Global Recombinant Human Interleukin-2 Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Interleukin-2 Sales by Region (2025-2030) & (kg)
Table 20. Global Recombinant Human Interleukin-2 Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Interleukin-2 Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Interleukin-2 Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Interleukin-2 Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Interleukin-2 Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 27. North America Recombinant Human Interleukin-2 Sales by Country (2025-2030) & (kg)
Table 28. North America Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 32. Europe Recombinant Human Interleukin-2 Sales by Country (2025-2030) & (kg)
Table 33. Europe Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Interleukin-2 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Interleukin-2 Sales by Region (2019-2024) & (kg)
Table 37. Asia Pacific Recombinant Human Interleukin-2 Sales by Region (2025-2030) & (kg)
Table 38. Asia Pacific Recombinant Human Interleukin-2 Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Interleukin-2 Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 42. Latin America Recombinant Human Interleukin-2 Sales by Country (2025-2030) & (kg)
Table 43. Latin America Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 47. Middle East and Africa Recombinant Human Interleukin-2 Sales by Country (2025-2030) & (kg)
Table 48. Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Interleukin-2 Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Interleukin-2 Sales (kg) by Type (2019-2024)
Table 51. Global Recombinant Human Interleukin-2 Sales (kg) by Type (2025-2030)
Table 52. Global Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Interleukin-2 Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Interleukin-2 Price (US$/g) by Type (2019-2024)
Table 59. Global Recombinant Human Interleukin-2 Price (US$/g) by Type (2025-2030)
Table 60. Global Recombinant Human Interleukin-2 Sales (kg) by Application (2019-2024)
Table 61. Global Recombinant Human Interleukin-2 Sales (kg) by Application (2025-2030)
Table 62. Global Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Interleukin-2 Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Interleukin-2 Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Interleukin-2 Price (US$/g) by Application (2019-2024)
Table 69. Global Recombinant Human Interleukin-2 Price (US$/g) by Application (2025-2030)
Table 70. Cytiva Company Information
Table 71. Cytiva Description and Business Overview
Table 72. Cytiva Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 73. Cytiva Recombinant Human Interleukin-2 Product
Table 74. Cytiva Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 78. Bio-Techne Recombinant Human Interleukin-2 Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. Lonza Company Information
Table 81. Lonza Description and Business Overview
Table 82. Lonza Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 83. Lonza Recombinant Human Interleukin-2 Product
Table 84. Lonza Recent Developments/Updates
Table 85. Sartorius CellGenix Company Information
Table 86. Sartorius CellGenix Description and Business Overview
Table 87. Sartorius CellGenix Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 88. Sartorius CellGenix Recombinant Human Interleukin-2 Product
Table 89. Sartorius CellGenix Recent Developments/Updates
Table 90. Thermo Fisher Scientific Company Information
Table 91. Thermo Fisher Scientific Description and Business Overview
Table 92. Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 93. Thermo Fisher Scientific Recombinant Human Interleukin-2 Product
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. Miltenyi Biotec Company Information
Table 96. Miltenyi Biotec Description and Business Overview
Table 97. Miltenyi Biotec Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 98. Miltenyi Biotec Recombinant Human Interleukin-2 Product
Table 99. Miltenyi Biotec Recent Developments/Updates
Table 100. Akron Biotech Company Information
Table 101. Akron Biotech Description and Business Overview
Table 102. Akron Biotech Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 103. Akron Biotech Recombinant Human Interleukin-2 Product
Table 104. Akron Biotech Recent Developments/Updates
Table 105. Sino Biological Company Information
Table 106. Sino Biological Description and Business Overview
Table 107. Sino Biological Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 108. Sino Biological Recombinant Human Interleukin-2 Product
Table 109. Sino Biological Recent Developments/Updates
Table 110. Creative Bioarray Company Information
Table 111. Creative Bioarray Description and Business Overview
Table 112. Creative Bioarray Recombinant Human Interleukin-2 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 113. Creative Bioarray Recombinant Human Interleukin-2 Product
Table 114. Creative Bioarray Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Recombinant Human Interleukin-2 Distributors List
Table 118. Recombinant Human Interleukin-2 Customers List
Table 119. Recombinant Human Interleukin-2 Market Trends
Table 120. Recombinant Human Interleukin-2 Market Drivers
Table 121. Recombinant Human Interleukin-2 Market Challenges
Table 122. Recombinant Human Interleukin-2 Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Interleukin-2
Figure 2. Global Recombinant Human Interleukin-2 Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Interleukin-2 Market Share by Type: 2023 & 2030
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Other Product Picture
Figure 6. Global Recombinant Human Interleukin-2 Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Human Interleukin-2 Market Share by Application: 2023 & 2030
Figure 8. Medical
Figure 9. Culture Medium Supplement
Figure 10. Scientific Research
Figure 11. Global Recombinant Human Interleukin-2 Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Interleukin-2 Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Human Interleukin-2 Sales (2019-2030) & (kg)
Figure 14. Global Recombinant Human Interleukin-2 Average Price (US$/g) & (2019-2030)
Figure 15. Recombinant Human Interleukin-2 Report Years Considered
Figure 16. Recombinant Human Interleukin-2 Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Human Interleukin-2 Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Recombinant Human Interleukin-2 Players: Market Share by Revenue in Recombinant Human Interleukin-2 in 2023
Figure 19. Recombinant Human Interleukin-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Human Interleukin-2 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 23. United States Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Interleukin-2 Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Human Interleukin-2 Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 42. Mexico Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Recombinant Human Interleukin-2 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Recombinant Human Interleukin-2 by Type (2019-2030)
Figure 52. Global Revenue Market Share of Recombinant Human Interleukin-2 by Type (2019-2030)
Figure 53. Global Recombinant Human Interleukin-2 Price (US$/g) by Type (2019-2030)
Figure 54. Global Sales Market Share of Recombinant Human Interleukin-2 by Application (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Human Interleukin-2 by Application (2019-2030)
Figure 56. Global Recombinant Human Interleukin-2 Price (US$/g) by Application (2019-2030)
Figure 57. Recombinant Human Interleukin-2 Value Chain
Figure 58. Recombinant Human Interleukin-2 Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
